Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications.
作者信息
Jiang Jipin, Miao Yan, Zhao Yuanyuan, Lu Xia, Zhou Ping, Zhou Xiaojun, Chen Zhishui, Du Dunfeng
机构信息
Institute of Organ Transplantation, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
出版信息
Clin Transplant. 2020 Sep;34(9):e14025. doi: 10.1111/ctr.14025. Epub 2020 Jul 15.
Abstract
摘要
相似文献
1
Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications.康复期血浆疗法：对一名出现严重临床表现和复杂并发症的肾移植受者的新型冠状病毒肺炎有效治疗。
Clin Transplant. 2020 Sep;34(9):e14025. doi: 10.1111/ctr.14025. Epub 2020 Jul 15.
2
Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy.三例肾移植受者接受恢复期血浆治疗后成功从 COVID-19 中康复。
Transpl Infect Dis. 2021 Feb;23(1):e13451. doi: 10.1111/tid.13451. Epub 2020 Sep 3.
3
Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.COVID-19 阳性肺炎肾移植受者成功接受脉冲甲基强的松龙和恢复期血浆治疗：病例报告。
Pan Afr Med J. 2021 Mar 16;38:273. doi: 10.11604/pamj.2021.38.273.28577. eCollection 2021.
4
Feasibility of Convalescent Plasma Therapy in Kidney Transplant Recipients With Severe COVID-19: A Single-Center Prospective Cohort Study.COVID-19 重症肾移植受者恢复期血浆治疗的可行性：一项单中心前瞻性队列研究。
Exp Clin Transplant. 2021 Apr;19(4):304-309. doi: 10.6002/ect.2020.0479. Epub 2021 Feb 17.
5
Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease.成功应用恢复期血浆疗法治疗一名患有严重冠状病毒病的儿童
Indian Pediatr. 2021 Jan 15;58(1):89-90. doi: 10.1007/s13312-021-2110-0. Epub 2020 Dec 1.
6
Efficacy of Convalescent Plasma to Treat Mild to Moderate COVID-19 in Kidney Transplant Patients: A Propensity Score Matching Analysis.恢复期血浆治疗肾移植患者轻至中度 COVID-19 的疗效：倾向评分匹配分析。
Transplantation. 2022 Jan 1;106(1):e92-e94. doi: 10.1097/TP.0000000000003962.
7
Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis.康复期血浆救治了一名患有慢性髓性白血病急变期和骨髓纤维化的重症新冠肺炎患者。
Turk J Haematol. 2021 Feb 25;18(1):74-76. doi: 10.4274/tjh.galenos.2020.2020.0400. Epub 2020 Sep 29.
8
Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City.COVID-19 患者进行实体器官移植后使用恢复期血浆治疗：来自纽约市大型移植中心的经验。
Clin Transplant. 2020 Dec;34(12):e14089. doi: 10.1111/ctr.14089. Epub 2020 Sep 28.
9
The Second Wave of COVID-19 Disease in a Kidney Transplant Recipient Cohort: A Single-center Experience in Belgium.肾移植受者队列中新冠病毒病的第二波疫情：比利时的单中心经验
Transplantation. 2021 Mar 1;105(3):e41-e42. doi: 10.1097/TP.0000000000003596.
10
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?静注人免疫球蛋白（pH4）治疗新型冠状病毒肺炎重型及危重型的专家推荐意见
Med Hypotheses. 2020 Nov;144:109903. doi: 10.1016/j.mehy.2020.109903. Epub 2020 May 31.
引用本文的文献
1
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 May 10;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub6.
2
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5.
3
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.COVID-19 恢复期血浆治疗免疫功能低下患者：系统评价和荟萃分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647.
4
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.“恢复期血浆”——预防新型冠状病毒肺炎的一种有效治疗选择——综述
Infect Disord Drug Targets. 2022;22(8):42-60. doi: 10.2174/1871526522666220425103031.
5
Coronavirus-19 infection in kidney transplant recipients: A comprehensive review.肾移植受者中的新型冠状病毒-19感染：一项综述
Indian J Urol. 2022 Apr-Jun;38(2):110-114. doi: 10.4103/iju.iju_430_21. Epub 2022 Apr 1.
6
Perplexing issues for convalescent immune plasma therapy in COVID-19.新冠康复期免疫血浆疗法面临的棘手问题。
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
7
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review.恢复期血浆疗法治疗冠状病毒的免疫效果：范围综述。
BMC Infect Dis. 2021 Dec 24;21(1):1278. doi: 10.1186/s12879-021-06981-0.
8
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.SARS-CoV-2 在实体器官移植受者中的研究进展：2020 年的系统综述
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
9
Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.COVID-19 阳性肺炎肾移植受者成功接受脉冲甲基强的松龙和恢复期血浆治疗：病例报告。
Pan Afr Med J. 2021 Mar 16;38:273. doi: 10.11604/pamj.2021.38.273.28577. eCollection 2021.
10
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic.新型冠状病毒病 2019 与肝移植：大流行第一年的经验教训。
Liver Transpl. 2021 Sep;27(9):1312-1325. doi: 10.1002/lt.26194. Epub 2021 Jul 31.
本文引用的文献
1
A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals.一项关于新冠康复期血浆治疗的随机试验——潜在的希望信号
JAMA. 2020 Aug 4;324(5):455-457. doi: 10.1001/jama.2020.10218.
2
Covid-19 and Kidney Transplantation.新冠病毒-19与肾移植
N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24.
3
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.韩国两名急性呼吸窘迫综合征 COVID-19 患者使用恢复期血浆疗法。
J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.
4
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.恢复期血浆和高效免疫球蛋白治疗病毒性病因严重急性呼吸道感染的有效性：系统评价与探索性Meta分析
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.
Zotero 插件